Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Sep 30
Love0

Skin Barrier Benefits of a Natural Moisturizing Factor and Lipids-Based Moisturizer for Clinically Sensitive Skin

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD), rosacea, and cosmetic intolerance syndrome (CIS) are clinically associated with disrupted skin barrier function (eg, increased transepidermal water loss ) and skin sensitivity that manifests as dryness,…
Read More
Sep 30
Love0

SAIGE I: Staphylococcus aureus, Immunological, Genetic, and Environmental (SAIGE) Factors Contributing to Atopic Dermatitis and the Use of Ceramide-Containing Skincare

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a chronic inflammatory skin disease typically with onset in infancy or early childhood and may persist into adulthood, with a prevalence of up to 20% in…
Read More
Sep 30
Love0

Real-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD), also known as atopic eczema, is a chronic inflammatory disorder characterized by recurrent eczematous lesions, intense itch, and lichenification.1 Although typically beginning in childhood, AD can manifest…
Read More
Sep 30
Love0

FULL SUPPLEMENT: Time To Get Hands On: Delgocitinib’s Promise For Chronic Hand Eczema

By Chuck Lin No Comments
In this issue:VEHICLES MATTERChronic hand eczema (CHE), which affects up to 10% of the United States population annually, encompasses a diverse range of presentations. Designation of the condition as "chronic"…
Read More
Sep 30
Love0

INDIVIDUAL ARTICLE: VEHICLES MATTER

By Chuck Lin No Comments
Chronic hand eczema (CHE), which affects up to 10% of the United States population annually, encompasses a diverse range of presentations. Designation of the condition as "chronic" owes to its…
Read More
Sep 30
Love0

INDIVIDUAL ARTICLE: The Utility of Delgocitinib in Chronic Hand Eczema

By Chuck Lin No Comments
INTRODUCTIONChronic hand eczema (CHE) is a common, relapsing inflammatory skin condition characterized by redness, scaling, fissures, and intense itching or pain that can severely impair hand function and quality of…
Read More
Sep 29
Love0

The Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a common inflammatory skin disease that can significantly affect a patient's quality of life. The pathogenesis of AD is multifactorial and is associated with the dysregulation…
Read More
Sep 29
Love0

Examining an Antioxidant Biostimulating Treatment for Dark, Postinflammatory Hyperpigmentation-Prone Skin

By Chuck Lin No Comments
INTRODUCTIONSkin rejuvenation treatments, including chemical peels and biostimulatory therapies, improve signs of aging; however, they have limitations, including invasiveness, efficacy, safety, and extensive downtime.1Chemical peels are well-known for skin rejuvenation…
Read More
Sep 29
Love0

Ruxolitinib Cream Versus Triamcinolone Cream in Adults With Mild to Moderate Atopic Dermatitis

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease.1 Although topical corticosteroids are the mainstay of therapy in patients with mild to moderate AD, a need for alternative…
Read More
Sep 29
Love0

1% Colloidal Oatmeal Cream/Baby Wash Regimen Improved Atopic Dermatitis in Pediatric Patients From First Use

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD), the most common chronic inflammatory skin disease, affects 15% to 20% of infants/children, with symptoms generally developing by 1 year of age.1 Pruritus and inflammatory lesions (typically…
Read More
Sep 22
Love0

A Qualitative Assessment of Chatbots for Common Dermatologic Conditions

By Chuck Lin No Comments
INTRODUCTIONArtificial Intelligence (AI) chatbots have become increasingly popular tools for patients seeking health information. The ability of AI chatbots to offer accurate, understandable, and reliable information for common conditions can…
Read More
Sep 22
Love0

Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report

By Chuck Lin No Comments
INTRODUCTIONLinear IgA bullous dermatosis (LABD), also known as IgA pemphigoid, is an acquired autoimmune sub-epidermal vesiculobullous disease. Patients with LABD can experience intense pruritus with burning and pain, which may…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • New Innovations of SkinCeuticals and Integrated Skincare October 23, 2025
  • Understanding Topical Steroid Withdrawal: Where Are We Now? October 23, 2025
  • Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis October 22, 2025
  • JDD Welcomes Our Newest Editorial Board Member October 21, 2025
  • From the Vault: Novel Strategy for Strengthening Dermatoporotic Skin by Managing Cellular Senescence October 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Acne
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search